The main objectives of the Clinical Neuroimmunology group through research are to improve the quality of life of persons living with multiple sclerosis (MS) and attain a greater understanding of the pathogenic mechanisms, aiming to develop new and more effective therapeutic means. Other interests in research are: therapeutic tools in MS; disease susceptibility, diagnostic and prognostic markers in MS; study of the response to interferon-beta treatment in MS patients; clinical and radiological study of primary-progressive MS; research for therapeutic targets and/or therapeutic approaches; epidemiology of MS.
